1
|
Zeshan M, Bhatti IA, Mohsin M, Iqbal M, Amjed N, Nisar J, AlMasoud N, Alomar TS. Remediation of pesticides using TiO 2 based photocatalytic strategies: A review. Chemosphere 2022; 300:134525. [PMID: 35427656 DOI: 10.1016/j.chemosphere.2022.134525] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Revised: 03/31/2022] [Accepted: 04/03/2022] [Indexed: 06/14/2023]
Abstract
Nowadays, pesticides are regarded as the most dangerous of the various organic pollutants, posing substantial environmental and human threats worldwide. Pesticide contamination has become one of the most crucial environmental issues due to its bio-persistence and bioaccumulation. Different conventional methods are being utilized for pesticide removal, yet pesticides are thought to be significantly present in the environment. The development and application of sophisticated wastewater treatment methods are being pursued to remove contaminants effectively, particularly pesticides. In the past several decades, nanoscience and nanotechnology have emerged as essential tools for the identification, removal, and mineralization of persistent pesticides by employing advanced nanomaterials such as pristine titanium dioxide (TiO2), doped TiO2, nanocomposites (NCs) TiO2, and ternary nanocomposites (TNCs) TiO2 by advanced oxidation processes (AOPs). Advancement in the characteristics of TiO2 by doping, co-doping, construction of NCs and TNCs has contributed to the dramatic efficiency up-gradation by reducing band gap, solar active photocatalyst, enhancing PCA, high photostability, chemically inertness and multiple time reusability. Based on previous literature, utilizing La-TiO2 NCs photocatalyst, the mineralization of pesticide (imidacloprid) attained up to 98.17% that is almost 40-53% greater than pristine TiO2. The present review attempt to discuss the recent research performed on TiO2 based nanoparticles (NPs) and NCs for photocatalytic mineralization of various pesticides. The basic mechanism of TiO2 photocatalysis, types of reactors used for photocatalysis, and optimized experimental conditions of TiO2 for pesticides mineralization are discussed.
Collapse
Affiliation(s)
- Muhammad Zeshan
- Department of Chemistry, University of Agriculture, Faisalabad, 38040, Pakistan
| | - Ijaz A Bhatti
- Department of Chemistry, University of Agriculture, Faisalabad, 38040, Pakistan.
| | - Muhammad Mohsin
- Department of Chemistry, University of Agriculture, Faisalabad, 38040, Pakistan.
| | - Munawar Iqbal
- Department of Chemistry, Division of Science and Technology, University of Education, Lahore, Pakistan.
| | - Nyla Amjed
- Department of Chemistry, The University of Lahore, Lahore, 53700, Pakistan
| | - Jan Nisar
- National Centre of Excellence in Physical Chemistry, University of Peshawar, Peshawar, 25120, Pakistan
| | - Najla AlMasoud
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi Arabia
| | - Taghrid S Alomar
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi Arabia
| |
Collapse
|
2
|
Nisar J, Khan MA, Ali G, Iqbal M, Din MI, Hussain Z, Bhatti IA, Al-Kadhi NS, Alamro FS. Polypropylene pyrolysis kinetics under isothermal and non-isothermal conditions: a comparative analysis. Z PHYS CHEM 2022. [DOI: 10.1515/zpch-2022-0005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
The kinetics of polypropylene pyrolysis has been studied under isothermal and non-isothermal conditions using Arrhenius and Kissinger–Akahira–Sunose (KAS) equations. Under isothermal conditions, applying first order kinetic model, activation energy (Ea) and pre-exponential factor (A) were investigated and observed as 119.7 kJ mol−1 and 1.2 × 1010 min−1, while in case of non-isothermal kinetics using Kissinger–Akahira–Sunose method, the average Ea and A were found to be 91.23 kJ mol−1 and 2.3 × 107 min−1, respectively. A comparison among the isothermal and non-isothermal reactions was made on the basis of kinetics parameters. The results from both the methods showed trivial variation in kinetic parameters of the pyrolysis reaction which may be due to two major reasons. Firstly, the selection of the kinetic model applied and secondly the inconsistency due to various experimental conditions used which can be reduced at optimized conditions. As the disposal of plastic materials need reliable kinetics information to model their decomposition reactions, therefore, the kinetics data thus obtained from pyrolysis reaction of model polypropylene will help in the utilization of polypropylene waste as energy source on industrial scale.
Collapse
Affiliation(s)
- Jan Nisar
- National Centre of Excellence in Physical Chemistry , University of Peshawar , 25120 , Peshawar , Pakistan
| | - Muhammad A. Khan
- National Centre of Excellence in Physical Chemistry , University of Peshawar , 25120 , Peshawar , Pakistan
| | - Ghulam Ali
- National Centre of Excellence in Physical Chemistry , University of Peshawar , 25120 , Peshawar , Pakistan
| | - Munawar Iqbal
- Department of Chemistry, Division of Science and Technology , University of Education , Lahore , Pakistan
| | - Muhammad Imran Din
- School of Chemistry , University of the Punjab , 54590 , Lahore , Pakistan
| | - Zaib Hussain
- School of Chemistry , University of the Punjab , 54590 , Lahore , Pakistan
| | - Ijaz A. Bhatti
- Department of Chemistry , University of Agriculture , 38000 , Faisalabad , Pakistan
| | - Nada S. Al-Kadhi
- Department of Chemistry , College of Sciences, Princess Nourah bint Abdulrahman University , P.O. Box 84428 11671 , Riyadh , Saudi Arabia
| | - Fowzia S. Alamro
- Department of Chemistry , College of Sciences, Princess Nourah bint Abdulrahman University , P.O. Box 84428 11671 , Riyadh , Saudi Arabia
| |
Collapse
|
3
|
Heilig CE, Horak P, Kreutzfeldt S, Teleanu V, Mock A, Renner M, Bhatti IA, Hutter B, Hüllein J, Fröhlich M, Uhrig S, Süße H, Heiligenthal L, Ochsenreither S, Illert AL, Vogel A, Desuki A, Heinemann V, Heidegger S, Bitzer M, Scheytt M, Brors B, Hübschmann D, Baretton G, Stenzinger A, Steindorf K, Benner A, Jäger D, Heining C, Glimm H, Fröhling S, Schlenk RF. Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial. ESMO Open 2021; 6:100310. [PMID: 34808524 PMCID: PMC8609144 DOI: 10.1016/j.esmoop.2021.100310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Accepted: 10/27/2021] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Approvals of cancer therapeutics are primarily disease entity specific. Current molecular diagnostic approaches frequently identify actionable alterations in rare cancers or rare subtypes of common cancers for which the corresponding treatments are not approved and unavailable within clinical trials due to entity-related eligibility criteria. Access may be negotiated with health insurances. However, approval rates vary, and critical information required for a scientific evaluation of treatment-associated risks and benefits is not systematically collected. Thus clinical trials with optimized patient selection and comprehensive molecular characterization are essential for translating experimental treatments into standard care. PATIENTS AND METHODS Continuous ReAssessment with Flexible ExTension in Rare Malignancies (CRAFT) is an open-label phase II trial for adults with pretreated, locally advanced, or metastatic solid tumors. Based on the evaluation by a molecular tumor board, patients are assigned to combinations of six molecularly targeted agents and a programmed death-ligand 1 (PD-L1) antagonist within seven study arms focusing on (i) BRAF V600 mutations; (ii) ERBB2 amplification and/or overexpression, activating ERBB2 mutations; (iii) ALK rearrangements, activating ALK mutations; (iv and v) activating PIK3CA and AKT mutations, other aberrations predicting increased PI3K-AKT pathway activity; (vi) aberrations predicting increased RAF-MEK-ERK pathway activity; (vii) high tumor mutational burden and other alterations predicting sensitivity to PD-L1 inhibition. The primary endpoint is the disease control rate (DCR) at week 16; secondary and exploratory endpoints include the progression-free survival ratio, overall survival, and patient-reported outcomes. Using Simon's optimal two-stage design, 14 patients are accrued for each study arm. If three or fewer patients achieve disease control, the study arm is stopped. Otherwise, 11 additional patients are accrued. If the DCR exceeds 7 of 25 patients, the null hypothesis is rejected for the respective study arm. CONCLUSIONS CRAFT was activated in October 2021 and will recruit at 10 centers in Germany. TRIAL REGISTRATION NUMBERS EudraCT: 2019-003192-18; ClinicalTrials.gov: NCT04551521.
Collapse
Affiliation(s)
- C E Heilig
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany
| | - P Horak
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany
| | - S Kreutzfeldt
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany
| | - V Teleanu
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
| | - A Mock
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany
| | - M Renner
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany
| | - I A Bhatti
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany
| | - B Hutter
- Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany
| | - J Hüllein
- Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany
| | - M Fröhlich
- Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany
| | - S Uhrig
- Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany
| | - H Süße
- NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany
| | - L Heiligenthal
- NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany
| | - S Ochsenreither
- Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany; DKTK, Berlin, Germany
| | - A L Illert
- Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; DKTK, Freiburg, Germany
| | - A Vogel
- Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
| | - A Desuki
- University Cancer Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, Mainz, Germany; Third Medical Department, University Medical Center, Mainz, Germany
| | - V Heinemann
- Department of Medicine III, University Hospital, Ludwig Maximilians University Munich, Munich, Germany; DKTK, Munich, Germany
| | - S Heidegger
- DKTK, Munich, Germany; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany
| | - M Bitzer
- Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany; Department of Internal Medicine I, University Hospital, Eberhard-Karls University, Tübingen, Germany; DKTK, Tübingen, Germany
| | - M Scheytt
- Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany; Department of Internal Medicine II, Würzburg University Medical Center, Würzburg, Germany
| | - B Brors
- German Cancer Consortium (DKTK), Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany
| | - D Hübschmann
- German Cancer Consortium (DKTK), Heidelberg, Germany; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany
| | - G Baretton
- Institute for Pathology, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany
| | - A Stenzinger
- German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany
| | - K Steindorf
- Division of Physical Activity, Prevention and Cancer, NCT Heidelberg and DKFZ, Heidelberg, Germany
| | - A Benner
- Division of Biostatistics, DKFZ, Heidelberg, Germany
| | - D Jäger
- Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany
| | - C Heining
- Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; DKTK, Dresden, Germany
| | - H Glimm
- Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; DKTK, Dresden, Germany
| | - S Fröhling
- Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany
| | - R F Schlenk
- German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany.
| |
Collapse
|
4
|
Shaheen M, Bhatti IA, Ashar A, Mohsin M, Nisar J, Almoneef MM, Iqbal M. Synthesis of Cu-doped MgO and its enhanced photocatalytic activity for the solar-driven degradation of disperse red F3BS with condition optimization. Z PHYS CHEM 2021. [DOI: 10.1515/zpch-2020-1741] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Abstract
In the present study, Cu (2–12%) doped MgO was synthesized and characterized by SEM, XRD, EDX, and FTIR spectroscopy. The Cu concentration significantly affected the band gap and particle size, which ranged from 4.63 to 3.78 eV and from 27.2 to 79 nm, respectively. In addition, the photocatalytic activity (PCA) of Cu-doped MgO was monitored by the photocatalytic destruction of disperse red F3BS coralene dye, and four reaction variables such as dye concentration, catalyst dose, hydrogen peroxide concentration, and irradiation time, respectively, were optimized by response surface methodology (RSM). Dye degradation was significantly affected by these process variables, and a degradation rate of up to 93% was achieved under optimized conditions. The wastewater samples were also treated under optimized conditions and water quality variables, i.e., chemical oxygen demand (COD) and biochemical oxygen demand (BOD) were significantly improved after treatment. Cu-doped MgO exhibited excellent PCA under the solar-light exposure for the degradation of disperse red F3BS dye, which can be employed for the treatment of dye-containing effluents.
Collapse
Affiliation(s)
- Musarrat Shaheen
- Department of Chemistry , University of Agriculture , Faisalabad 38040 , Pakistan
| | - Ijaz A. Bhatti
- Department of Chemistry , University of Agriculture , Faisalabad 38040 , Pakistan
| | - Ambreen Ashar
- Department of Chemistry , Government College Women University , Faisalabad 38040 , Pakistan
| | - Muhammad Mohsin
- Department of Chemistry , University of Agriculture , Faisalabad 38040 , Pakistan
| | - Jan Nisar
- National Center of Excellence in Physical Chemistry, University of Peshawar , Peshawar 25120 , Pakistan
| | - Maha M. Almoneef
- Department of Physics , College of Sciences, Princess Nourah bint Abdulrahman University (PNU) , Riyadh 11671 , Saudi Arabia
| | - Munawar Iqbal
- Department of Chemistry , The University of Lahore , Lahore 53700 , Pakistan
| |
Collapse
|